ビジネス · 2002/2/111 分で読めます
Aventis Pharmaceuticals et al.; Withdrawal of Approval of 12 New Drug Applications
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing approval of 12 new drug applications (NDAs). The holders of the applications notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.